Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2023

Nov 27, 2023

5250_mrq_2023-11-27_dcbe206f-12c1-4861-81c1-71b3ece853f8.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7918U

Barclays PLC

27 November 2023

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose DECHRA PHARMACEUTICALS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 24 Nov 2023
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: 1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 7,501,243 6.59% 1,002,826 0.88%
(2) Cash-settled derivatives:
and/or controlled: 993,746 0.87% 7,444,753 6.54%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 8,494,989 7.46% 8,447,579 7.42%
(b) Rights to subscribe for new securities (including directors and other executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
1p ordinary Purchase 183,620 38.2200  GBP
1p ordinary Purchase 14,538 38.2288  GBP
1p ordinary Purchase 4,110 38.2391  GBP
1p ordinary Purchase 2,488 38.2400  GBP
1p ordinary Purchase 839 38.2398  GBP
1p ordinary Purchase 348 38.2343  GBP
1p ordinary Purchase 170 38.2000  GBP
1p ordinary Purchase 146 38.2300  GBP
1p ordinary Sale 12,824 38.2200  GBP
1p ordinary Sale 10,927 38.2152  GBP
1p ordinary Sale 4,068 38.2005  GBP
1p ordinary Sale 3,584 38.2078  GBP
1p ordinary Sale 2,282 38.2175  GBP
1p ordinary Sale 2,204 38.2400  GBP
1p ordinary Sale 691 38.2150  GBP
1p ordinary Sale 258 38.2457  GBP
1p ordinary Sale 158 38.2000  GBP
1p ordinary Sale 45 38.2086  GBP
1p ordinary Sale 26 38.2046  GBP
1p ordinary Sale 3 38.2018  GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
1p ordinary SWAP Long 3 38.2018  GBP
1p ordinary SWAP Long 40 38.2117  GBP
1p ordinary SWAP Long 45 38.2086  GBP
1p ordinary SWAP Long 206 38.2200  GBP
1p ordinary SWAP Long 2,193 38.2400  GBP
1p ordinary SWAP Long 2,282 38.2175  GBP
1p ordinary SWAP Long 3,867 38.2099  GBP
1p ordinary SWAP Long 4,634 38.2005  GBP
1p ordinary SWAP Long 10,927 38.2152  GBP
1p ordinary CFD Short 511 38.2228  GBP
1p ordinary SWAP Short 839 38.2398  GBP
1p ordinary CFD Short 945 38.2251  GBP
1p ordinary SWAP Short 1,827 38.2391  GBP
1p ordinary CFD Short 2,283 38.2391  GBP
1p ordinary SWAP Short 4,534 38.2252  GBP
1p ordinary SWAP Short 7,661 38.2393  GBP
1p ordinary SWAP Short 175,876 38.2200  GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 27 Nov 2023
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEAAFXAESDFFA